178 related articles for article (PubMed ID: 25734215)
1. Characterization of UBO-QIC as a Gαq inhibitor in platelets.
Inamdar V; Patel A; Manne BK; Dangelmaier C; Kunapuli SP
Platelets; 2015; 26(8):771-8. PubMed ID: 25734215
[TBL] [Abstract][Full Text] [Related]
2. On the selectivity of the Gαq inhibitor UBO-QIC: A comparison with the Gαi inhibitor pertussis toxin.
Gao ZG; Jacobson KA
Biochem Pharmacol; 2016 May; 107():59-66. PubMed ID: 26954502
[TBL] [Abstract][Full Text] [Related]
3. G
Badolia R; Inamdar V; Manne BK; Dangelmaier C; Eble JA; Kunapuli SP
J Biol Chem; 2017 Sep; 292(35):14516-14531. PubMed ID: 28705934
[TBL] [Abstract][Full Text] [Related]
4. Biological properties of a specific Galpha q/11 inhibitor, YM-254890, on platelet functions and thrombus formation under high-shear stress.
Uemura T; Kawasaki T; Taniguchi M; Moritani Y; Hayashi K; Saito T; Takasaki J; Uchida W; Miyata K
Br J Pharmacol; 2006 May; 148(1):61-9. PubMed ID: 16520742
[TBL] [Abstract][Full Text] [Related]
5. Role of heterotrimeric G proteins in platelet activation and clot formation in platelets treated with integrin αIIbβ3 inhibitor.
Budnik I; Shenkman B; Hauschner H; Zilinsky I; Savion N
Platelets; 2018 May; 29(3):265-269. PubMed ID: 28406726
[TBL] [Abstract][Full Text] [Related]
6. ADP induces partial platelet aggregation without shape change and potentiates collagen-induced aggregation in the absence of Galphaq.
Ohlmann P; Eckly A; Freund M; Cazenave JP; Offermanns S; Gachet C
Blood; 2000 Sep; 96(6):2134-9. PubMed ID: 10979958
[TBL] [Abstract][Full Text] [Related]
7. Do heterotrimeric G proteins redistribute upon G protein-coupled receptor stimulation in platelets?
Kahner BN; Quinton TM; Langan S; Kunapuli SP
Platelets; 2006 Sep; 17(6):397-404. PubMed ID: 16973501
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of the Gβ5-RGS7 complex on muscarinic M3 receptor-induced Ca2+ influx and release.
Karpinsky-Semper D; Volmar CH; Brothers SP; Slepak VZ
Mol Pharmacol; 2014 May; 85(5):758-68. PubMed ID: 24586057
[TBL] [Abstract][Full Text] [Related]
9. An experimental strategy to probe Gq contribution to signal transduction in living cells.
Patt J; Alenfelder J; Pfeil EM; Voss JH; Merten N; Eryilmaz F; Heycke N; Rick U; Inoue A; Kehraus S; Deupi X; Müller CE; König GM; Crüsemann M; Kostenis E
J Biol Chem; 2021; 296():100472. PubMed ID: 33639168
[TBL] [Abstract][Full Text] [Related]
10. Ga
Kamato D; Mitra P; Davis F; Osman N; Chaplin R; Cabot PJ; Afroz R; Thomas W; Zheng W; Kaur H; Brimble M; Little PJ
Cell Mol Life Sci; 2017 Apr; 74(8):1379-1390. PubMed ID: 27815595
[TBL] [Abstract][Full Text] [Related]
11. Evidence for cross-talk between glycoprotein VI and Gi-coupled receptors during collagen-induced platelet aggregation.
Nieswandt B; Bergmeier W; Eckly A; Schulte V; Ohlmann P; Cazenave JP; Zirngibl H; Offermanns S; Gachet C
Blood; 2001 Jun; 97(12):3829-35. PubMed ID: 11389023
[TBL] [Abstract][Full Text] [Related]
12. Role of G protein-gated inwardly rectifying potassium channels in P2Y12 receptor-mediated platelet functional responses.
Shankar H; Murugappan S; Kim S; Jin J; Ding Z; Wickman K; Kunapuli SP
Blood; 2004 Sep; 104(5):1335-43. PubMed ID: 15142872
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic lineage cell-specific protein-1 (HS1) regulates PAR-mediated ERK activation and thromboxane generation in platelets.
Kahner BN; Dorsam RT; Kim S; Shankar H; Kitamura D; Kunapuli SP
Platelets; 2008 Dec; 19(8):614-23. PubMed ID: 19012179
[TBL] [Abstract][Full Text] [Related]
14. AlphaIIbbeta3-mediated outside-in signaling induced by the agonist peptide LSARLAF utilizes ADP and thromboxane A2 receptors to cause alpha-granule secretion by platelets.
Cho MJ; Liu J; Pestina TI; Steward SA; Jackson CW; Gartner TK
J Thromb Haemost; 2003 Feb; 1(2):363-73. PubMed ID: 12871512
[TBL] [Abstract][Full Text] [Related]
15. Evidence for a role for Galphai1 in mediating weak agonist-induced platelet aggregation in human platelets: reduced Galphai1 expression and defective Gi signaling in the platelets of a patient with a chronic bleeding disorder.
Patel YM; Patel K; Rahman S; Smith MP; Spooner G; Sumathipala R; Mitchell M; Flynn G; Aitken A; Savidge G
Blood; 2003 Jun; 101(12):4828-35. PubMed ID: 12609843
[TBL] [Abstract][Full Text] [Related]
16. G-protein inhibition profile of the reported Gq/11 inhibitor UBO-QIC.
Kukkonen JP
Biochem Biophys Res Commun; 2016 Jan; 469(1):101-107. PubMed ID: 26614908
[TBL] [Abstract][Full Text] [Related]
17. ADP secretion and subsequent P2Y12 receptor signalling play a crucial role in thrombin-induced ERK2 activation in human platelets.
Fälker K; Lange D; Presek P
Thromb Haemost; 2004 Jul; 92(1):114-23. PubMed ID: 15213852
[TBL] [Abstract][Full Text] [Related]
18. Role of phosphoinositide 3-kinase beta in platelet aggregation and thromboxane A2 generation mediated by Gi signalling pathways.
Garcia A; Kim S; Bhavaraju K; Schoenwaelder SM; Kunapuli SP
Biochem J; 2010 Jul; 429(2):369-77. PubMed ID: 20441566
[TBL] [Abstract][Full Text] [Related]
19. High molecular weight kininogen inhibits thrombin-induced platelet aggregation and cleavage of aggregin by inhibiting binding of thrombin to platelets.
Puri RN; Zhou F; Hu CJ; Colman RF; Colman RW
Blood; 1991 Feb; 77(3):500-7. PubMed ID: 1846761
[TBL] [Abstract][Full Text] [Related]
20. Relative contribution of G-protein-coupled pathways to protease-activated receptor-mediated Akt phosphorylation in platelets.
Kim S; Jin J; Kunapuli SP
Blood; 2006 Feb; 107(3):947-54. PubMed ID: 16223779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
